Department of Nephrology, Hannover Medical School, Hannover, Germany.
Institute of Transfusion Medicine and Transplant Engineering, Hannover Medical School, Hannover, Germany.
PLoS One. 2022 Mar 4;17(3):e0265002. doi: 10.1371/journal.pone.0265002. eCollection 2022.
Acute kidney injury (AKI) after lung transplantation (LuTx) is associated with increased long-term mortality. In this prospective observational study, commonly used AKI-definitions were examined regarding prediction of long-term mortality and compared to simple use of the serum creatinine value at day 7 for patients who did not receive hemodialysis, and serum creatinine value immediately before initiation of hemodialysis (d7/preHD-sCr).
185 patients with LuTx were prospectively enrolled from 2013-2014 at our center. Kidney injury was assessed within 7 days by: (1) the Kidney Disease Improving Global Outcomes criteria (KDIGO-AKI), (2) the Acute Disease Quality Initiative 16 Workgroup classification (ADQI-AKI) and (3) d7/preHD-sCr. Prediction of all-cause mortality was examined by Cox regression analysis, and clinical as well as laboratory factors for impaired kidney function post-LuTx were analyzed.
AKI according to KDIGO and ADQI-AKI occurred in 115 patients (62.2%) within 7 days after LuTx. Persistent ADQI-AKI, KDIGO-AKI stage 3 and higher d7/preHD-sCr were associated with higher mortality in the univariable analysis. In the multivariable analysis, d7/preHD-sCr in combination with body weight and intra- and postoperative platelet transfusions predicted mortality after LuTx with similar performance as models using KDIGO-AKI and ADQI-AKI (concordance index of 0.75 for d7/preHD-sCr vs., 0.74 and 0.73, respectively). Pre-transplant reduced renal function, diabetes, higher BMI, and intraoperative ECMO predicted higher d7/preHD-sCr (r2 = 0.354, p < 0.001).
Our results confirm the importance of AKI in lung transplant patients; however, a simple and pragmatic indicator of renal function, d7/preHD-sCr, predicts long-term mortality equally reliable as more complex AKI-definitions like KDIGO and ADQI.
肺移植(LuTx)后急性肾损伤(AKI)与长期死亡率增加相关。在这项前瞻性观察研究中,我们检查了常用的 AKI 定义,以预测长期死亡率,并将其与未接受血液透析患者的第 7 天血清肌酐值(d7/preHD-sCr)和开始血液透析前即刻的血清肌酐值(d7/preHD-sCr)进行比较。
2013-2014 年,我们在中心前瞻性纳入了 185 例 LuTx 患者。在 7 天内通过以下方法评估肾脏损伤:(1)肾脏疾病改善全球结局标准(KDIGO-AKI),(2)急性疾病质量倡议 16 工作组分类(ADQI-AKI),和(3)d7/preHD-sCr。使用 Cox 回归分析检查全因死亡率的预测,分析 LuTx 后肾功能障碍的临床和实验室因素。
LuTx 后 7 天内,115 例(62.2%)患者发生 KDIGO 和 ADQI-AKI。在单变量分析中,持续性 ADQI-AKI、KDIGO-AKI 第 3 期和更高的 d7/preHD-sCr 与更高的死亡率相关。在多变量分析中,d7/preHD-sCr 联合体重、术中及术后血小板输注可预测 LuTx 后死亡率,与使用 KDIGO-AKI 和 ADQI-AKI 的模型具有相似的性能(d7/preHD-sCr 的一致性指数为 0.75,分别为 0.74 和 0.73)。移植前肾功能减退、糖尿病、较高的 BMI 和术中 ECMO 预测更高的 d7/preHD-sCr(r2=0.354,p<0.001)。
我们的结果证实了 AKI 在肺移植患者中的重要性;然而,一种简单实用的肾功能指标 d7/preHD-sCr,预测长期死亡率的可靠性与 KDIGO 和 ADQI 等更复杂的 AKI 定义相当。